Virus

¿Es el plasma de convalecientes un tratamiento para la COVID-19?

9 days ago   |   By Discovery's Edge

A fin de encontrar un tratamiento para los pacientes con COVID-19, los investigadores de todo el mundo exploran incansablemente numerosos ángulos, incluida la realización de pruebas con fármacos antivirales existentes y otros compuestos nuevos. Entre todo, llama la atención un posible tratamiento conocido como terapia con plasma de convalecientes que consiste en administrar a los pacientes enfermos una infusión de plasma rico en anticuerpos, obtenido de quienes se han recuperado de la infección por SARS-CoV-2, que es el virus causante de la COVID-19.
Los anticuerpos son el medio empleado...
Read more ...

 

Importancia de la prueba de anticuerpos para afrontar la COVID-19

Importancia de la prueba de anticuerpos para afrontar la COVID-19

9 days ago   |   By Discovery's Edge

Si el mundo algo ha aprendido durante el transcurso de la pandemia de la COVID-19, es la importancia de las pruebas para esta enfermedad. Tener la capacidad de saber quién tiene el virus y quién no está infectado se ha convertido en información vital para toda zona del planeta.
Las primeras pruebas consistían en obtener células de la parte posterior de la garganta o de los conductos nasales de los pacientes para detectar el material genético del SARS-CoV-2, virus que causa la COVID-19. Estos análisis se conocen como pruebas de la reacción en cadena de la polimerasa y detectan la presencia...
Read more ...

 


Search by Tags

   Virus      Clinical      COVID-19      En-espanol      Espanol      Plasma de convalecientes      La prueba de anticuerpos  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost

Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost badams Mon, 06/01/2020 - 07:56 Read more ...

AbbVie pens cancer pact with U.S.-China biotech Jacobio

AbbVie pens cancer pact with U.S.-China biotech Jacobio badams Mon, 06/01/2020 - 07:28 Read more ...

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the...

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action badams Mon, 06/01/2020 - 06:40 Read more ...

How a new biotech rule will foster distrust with the public and impede...

In May, federal regulators finalized a new biotechnology policy that will bring sweeping changes to the U.S. food system. Dubbed "SECURE," the rule revises U.S. Department of... Read more ...

FloChiP, a new tool optimizing gene-regulation studies

In the cell, proteins often interact directly with DNA to regulate and influence the expression of genes. For this to happen, proteins need to travel into the cell's nucleus... Read more ...

Researchers control cattle microbiomes to reduce methane and greenhouse gases

Ben-Gurion University of the Negev researchers have learned to control the microbiome of cattle for the first time which could inhibit their methane production, and therefore... Read more ...

Researchers develop biotechnological process for jasmonic acid production

Plants produce the hormone jasmonic acid as a defense response when challenged, making their leaves taste bad to predators. Biologists want to determine whether biological... Read more ...

Gossamer Bio Announces Participation in Upcoming Investor Conferences

SAN DIEGO--- $GOSS-Gossamer Bio, Inc. , a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutics in the disease... Read more ...

DelMar Pharmaceuticals to Present Updates of Two Phase 2 Clinical Trials of...

SAN DIEGO, June 1, 2020 /PRNewswire/ - DelMar Pharmaceuticals, Inc. , a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today... Read more ...

Inorganic Porous Nanoparticles for Drug Delivery in Antitumoral Therapy

Background The use of nanoparticles in oncology to deliver chemotherapeutic agents has received considerable attention in the last decades due to their tendency to be passively... Read more ...